Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Dec;92(6):2702–2712. doi: 10.1172/JCI116887

Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

L A Brown 1, D J Nunez 1, M R Wilkins 1
PMCID: PMC288468  PMID: 7902846

Abstract

The heart expresses the three natriuretic peptide receptors (NPR), namely NPR-A, NPR-B, and NPR-C. We have examined the temporal relationship between the expression of mRNA transcripts for atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and their receptors in the heart during the development of cardiac hypertrophy in the aortovenocaval fistula rat. Messenger RNAs were measured by cDNA amplification. Progressive cardiac hypertrophy was accompanied by increased ANP mRNA prevalence throughout the heart and increased BNP mRNA in the left atrium. The most striking observation was the gradual disappearance of NPR-C transcripts (the putative "clearance" receptor) in all chambers; this was in marked contrast to the increase in mRNA levels for NPR-A and NPR-B (the guanylyl cyclase-linked receptors). Our observations have important therapeutic implications if the transcript changes are mirrored at the receptor protein level because (a) the apparent down-regulation of NPR-C may enhance the local action of natriuretic peptides on the heart, and (b) the loss of NPR-C, particularly if it is widespread, may reduce the rate of elimination of the natriuretic peptides, restricting the therapeutic potential of specific NPR-C ligands designed to reduce peptide clearance.

Full text

PDF
2702

Images in this article

2707Image
on p.2707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aburaya M., Minamino N., Hino J., Kangawa K., Matsuo H. Distribution and molecular forms of brain natriuretic peptide in the central nervous system, heart and peripheral tissue of rat. Biochem Biophys Res Commun. 1989 Dec 15;165(2):880–887. doi: 10.1016/s0006-291x(89)80048-8. [DOI] [PubMed] [Google Scholar]
  2. Anand-Srivastava M. B., Cantin M. Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytes. Biochem Biophys Res Commun. 1986 Jul 16;138(1):427–436. doi: 10.1016/0006-291x(86)90299-8. [DOI] [PubMed] [Google Scholar]
  3. Anand-Srivastava M. B., Cantin M., Genest J. Inhibition of pituitary adenylate cyclase by atrial natriuretic factor. Life Sci. 1985 May 13;36(19):1873–1879. doi: 10.1016/0024-3205(85)90161-4. [DOI] [PubMed] [Google Scholar]
  4. Anand-Srivastava M. B., Sairam M. R., Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem. 1990 May 25;265(15):8566–8572. [PubMed] [Google Scholar]
  5. Anand-Srivastava M. B., Srivastava A. K., Cantin M. Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase. Involvement of inhibitory guanine nucleotide regulatory protein. J Biol Chem. 1987 Apr 15;262(11):4931–4934. [PubMed] [Google Scholar]
  6. Barclay P. L., Bennett J. A., Greengrass P. M., Griffin A., Samuels G. M., Shepperson N. B. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade. Biochem Pharmacol. 1992 Sep 25;44(6):1013–1022. doi: 10.1016/0006-2952(92)90362-m. [DOI] [PubMed] [Google Scholar]
  7. Barnett R., Ortiz P. A., Blaufox S., Singer S., Nord E. P., Ramsammy L. Atrial natriuretic factor alters phospholipid metabolism in mesangial cells. Am J Physiol. 1990 Jan;258(1 Pt 1):C37–C45. doi: 10.1152/ajpcell.1990.258.1.C37. [DOI] [PubMed] [Google Scholar]
  8. Bennett B. D., Bennett G. L., Vitangcol R. V., Jewett J. R., Burnier J., Henzel W., Lowe D. G. Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem. 1991 Dec 5;266(34):23060–23067. [PubMed] [Google Scholar]
  9. Berl T., Mansour J., Teitelbaum I. ANP stimulates phospholipase C in cultured RIMCT cells: roles of protein kinases and G protein. Am J Physiol. 1991 Apr;260(4 Pt 2):F590–F595. doi: 10.1152/ajprenal.1991.260.4.F590. [DOI] [PubMed] [Google Scholar]
  10. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 1985;82(5):441–452. doi: 10.1007/BF02450479. [DOI] [PubMed] [Google Scholar]
  11. Bloch K. D., Scott J. A., Zisfein J. B., Fallon J. T., Margolies M. N., Seidman C. E., Matsueda G. R., Homcy C. J., Graham R. M., Seidman J. G. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science. 1985 Dec 6;230(4730):1168–1171. doi: 10.1126/science.2933808. [DOI] [PubMed] [Google Scholar]
  12. Bowen-Pope D. F., Ross R. Methods for studying the platelet-derived growth factor receptor. Methods Enzymol. 1985;109:69–100. doi: 10.1016/0076-6879(85)09078-4. [DOI] [PubMed] [Google Scholar]
  13. Brenner B. M., Ballermann B. J., Gunning M. E., Zeidel M. L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990 Jul;70(3):665–699. doi: 10.1152/physrev.1990.70.3.665. [DOI] [PubMed] [Google Scholar]
  14. Chelly J., Concordet J. P., Kaplan J. C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2617–2621. doi: 10.1073/pnas.86.8.2617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chelly J., Kaplan J. C., Maire P., Gautron S., Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature. 1988 Jun 30;333(6176):858–860. doi: 10.1038/333858a0. [DOI] [PubMed] [Google Scholar]
  16. Chinkers M., Garbers D. L., Chang M. S., Lowe D. G., Chin H. M., Goeddel D. V., Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature. 1989 Mar 2;338(6210):78–83. doi: 10.1038/338078a0. [DOI] [PubMed] [Google Scholar]
  17. Clavell A. L., Stingo A. J., Wei C. M., Heublein D. M., Burnett J. C., Jr C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993 Feb;264(2 Pt 2):R290–R295. doi: 10.1152/ajpregu.1993.264.2.R290. [DOI] [PubMed] [Google Scholar]
  18. Cramb G., Banks R., Rugg E. L., Aiton J. F. Actions of atrial natriuretic peptide (ANP) on cyclic nucleotide concentrations and phosphatidylinositol turnover in ventricular myocytes. Biochem Biophys Res Commun. 1987 Nov 13;148(3):962–970. doi: 10.1016/s0006-291x(87)80226-7. [DOI] [PubMed] [Google Scholar]
  19. Dagnino L., Lavigne J. P., Nemer M. Increased transcripts for B-type natriuretic peptide in spontaneously hypertensive rats. Quantitative polymerase chain reaction for atrial and brain natriuretic peptide transcripts. Hypertension. 1992 Nov;20(5):690–700. doi: 10.1161/01.hyp.20.5.690. [DOI] [PubMed] [Google Scholar]
  20. Day M. L., Schwartz D., Wiegand R. C., Stockman P. T., Brunnert S. R., Tolunay H. E., Currie M. G., Standaert D. G., Needleman P. Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension. 1987 May;9(5):485–491. doi: 10.1161/01.hyp.9.5.485. [DOI] [PubMed] [Google Scholar]
  21. Drewett J. G., Ziegler R. J., Trachte G. J. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells. J Pharmacol Exp Ther. 1990 Nov;255(2):497–503. [PubMed] [Google Scholar]
  22. Drexler H., Hänze J., Finckh M., Lu W., Just H., Lang R. E. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation. 1989 Mar;79(3):620–633. doi: 10.1161/01.cir.79.3.620. [DOI] [PubMed] [Google Scholar]
  23. Fischer T. A., Haass M., Dietz R., Willenbrock R. C., Saggau W., Lang R. E., Kübler W. Transcription, storage and release of atrial natriuretic factor in the failing human heart. Clin Sci (Lond) 1991 Apr;80(4):285–291. doi: 10.1042/cs0800285. [DOI] [PubMed] [Google Scholar]
  24. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985 Mar 11;13(5):1431–1442. doi: 10.1093/nar/13.5.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fuller F., Porter J. G., Arfsten A. E., Miller J., Schilling J. W., Scarborough R. M., Lewicki J. A., Schenk D. B. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem. 1988 Jul 5;263(19):9395–9401. [PubMed] [Google Scholar]
  26. Gerdes A. M., Campbell S. E., Hilbelink D. R. Structural remodeling of cardiac myocytes in rats with arteriovenous fistulas. Lab Invest. 1988 Dec;59(6):857–861. [PubMed] [Google Scholar]
  27. Haass M., Fischer T. A., Hänze J., Saggau W., Lang R. E., Dietz R. Atrial natriuretic peptide mRNA in patients with heart disease. Am J Hypertens. 1990 Mar;3(3):234–236. doi: 10.1093/ajh/3.3.234. [DOI] [PubMed] [Google Scholar]
  28. Hirata M., Chang C. H., Murad F. Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim Biophys Acta. 1989 Mar 6;1010(3):346–351. doi: 10.1016/0167-4889(89)90060-8. [DOI] [PubMed] [Google Scholar]
  29. Hu R. M., Levin E. R., Pedram A., Frank H. J. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem. 1992 Aug 25;267(24):17384–17389. [PubMed] [Google Scholar]
  30. Huang M., Hester R. L., Guyton A. C. Hemodynamic changes in rats after opening an arteriovenous fistula. Am J Physiol. 1992 Mar;262(3 Pt 2):H846–H851. doi: 10.1152/ajpheart.1992.262.3.H846. [DOI] [PubMed] [Google Scholar]
  31. Isales C. M., Lewicki J. A., Nee J. J., Barrett P. Q. ANP-(7-23) stimulates a DHP-sensitive Ca2+ conductance and reduces cellular cAMP via a cGMP-independent mechanism. Am J Physiol. 1992 Aug;263(2 Pt 1):C334–C342. doi: 10.1152/ajpcell.1992.263.2.C334. [DOI] [PubMed] [Google Scholar]
  32. Katafuchi T., Mizuno T., Hagiwara H., Itakura M., Ito T., Hirose S. Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells. J Biol Chem. 1992 Apr 15;267(11):7624–7629. [PubMed] [Google Scholar]
  33. Kato J., Currie M. G. Suppression of atrial natriuretic peptide (ANP) receptor recovery from homologous down-regulation by 8-bromo-cGMP in endothelial cells. Eur J Pharmacol. 1992 Feb 13;225(2):113–117. doi: 10.1016/0922-4106(92)90090-i. [DOI] [PubMed] [Google Scholar]
  34. Kato J., Lanier-Smith K. L., Currie M. G. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J Biol Chem. 1991 Aug 5;266(22):14681–14685. [PubMed] [Google Scholar]
  35. Kato J., Misko T. P., Currie M. G. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells. Eur J Pharmacol. 1993 Jan 15;244(2):153–159. doi: 10.1016/0922-4106(93)90021-z. [DOI] [PubMed] [Google Scholar]
  36. Kato J., Oehlenschlager W. F., Newman W. H., Currie M. G. Inhibition of endothelial cell clearance of atrial natriuretic peptide by cyclic GMP treatment. Biochem Biophys Res Commun. 1992 Jan 15;182(1):420–424. doi: 10.1016/s0006-291x(05)80161-5. [DOI] [PubMed] [Google Scholar]
  37. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett. 1990 Dec 10;276(1-2):209–213. doi: 10.1016/0014-5793(90)80544-s. [DOI] [PubMed] [Google Scholar]
  38. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun. 1989 Mar 31;159(3):1420–1426. doi: 10.1016/0006-291x(89)92268-7. [DOI] [PubMed] [Google Scholar]
  39. Koller K. J., Goeddel D. V. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992 Oct;86(4):1081–1088. doi: 10.1161/01.cir.86.4.1081. [DOI] [PubMed] [Google Scholar]
  40. Koller K. J., Lowe D. G., Bennett G. L., Minamino N., Kangawa K., Matsuo H., Goeddel D. V. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991 Apr 5;252(5002):120–123. doi: 10.1126/science.1672777. [DOI] [PubMed] [Google Scholar]
  41. Lattion A. L., Michel J. B., Arnauld E., Corvol P., Soubrier F. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol. 1986 Nov;251(5 Pt 2):H890–H896. doi: 10.1152/ajpheart.1986.251.5.H890. [DOI] [PubMed] [Google Scholar]
  42. Lee R. T., Bloch K. D., Pfeffer J. M., Pfeffer M. A., Neer E. J., Seidman C. E. Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest. 1988 Feb;81(2):431–434. doi: 10.1172/JCI113337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lowe D. G., Camerato T. R., Goeddel D. V. cDNA sequence of the human atrial natriuretic peptide clearance receptor. Nucleic Acids Res. 1990 Jun 11;18(11):3412–3412. doi: 10.1093/nar/18.11.3412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lowe D. G., Chang M. S., Hellmiss R., Chen E., Singh S., Garbers D. L., Goeddel D. V. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J. 1989 May;8(5):1377–1384. doi: 10.1002/j.1460-2075.1989.tb03518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992;54:11–27. doi: 10.1146/annurev.ph.54.030192.000303. [DOI] [PubMed] [Google Scholar]
  46. MacFarland R. T., Zelus B. D., Beavo J. A. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J Biol Chem. 1991 Jan 5;266(1):136–142. [PubMed] [Google Scholar]
  47. Mantyh C. R., Kruger L., Brecha N. C., Mantyh P. W. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human. Hypertension. 1986 Aug;8(8):712–721. doi: 10.1161/01.hyp.8.8.712. [DOI] [PubMed] [Google Scholar]
  48. Meulemans A. L., Sipido K. R., Sys S. U., Brutsaert D. L. Atriopeptin III induces early relaxation of isolated mammalian papillary muscle. Circ Res. 1988 Jun;62(6):1171–1174. doi: 10.1161/01.res.62.6.1171. [DOI] [PubMed] [Google Scholar]
  49. Michel J. B., Salzmann J. L., Ossondo Nlom M., Bruneval P., Barres D., Camilleri J. P. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol. 1986 Mar-Apr;81(2):142–154. doi: 10.1007/BF01907379. [DOI] [PubMed] [Google Scholar]
  50. Mizuno T., Iwashina M., Itakura M., Hagiwara H., Hirose S. A variant form of the type C atrial natriuretic peptide receptor generated by alternative RNA splicing. J Biol Chem. 1993 Mar 5;268(7):5162–5167. [PubMed] [Google Scholar]
  51. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  52. Neyses L., Vetter H. Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes. Biochem Biophys Res Commun. 1989 Sep 29;163(3):1435–1443. doi: 10.1016/0006-291x(89)91139-x. [DOI] [PubMed] [Google Scholar]
  53. Nunez D. J., Davenport A. P., Brown M. J. Atrial natriuretic factor mRNA and binding sites in the adrenal gland. Biochem J. 1990 Oct 15;271(2):555–558. doi: 10.1042/bj2710555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Nunez D. J., Davenport A. P., Emson P. C., Brown M. J. A quantitative 'in-situ' hybridization method using computer-assisted image analysis. Validation and measurement of atrial-natriuretic-factor mRNA in the rat heart. Biochem J. 1989 Oct 1;263(1):121–127. doi: 10.1042/bj2630121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Nunez D. J., Dickson M. C., Brown M. J. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest. 1992 Nov;90(5):1966–1971. doi: 10.1172/JCI116075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Oehlenschlager W. F., Baron D. A., Schomer H., Currie M. G. Atrial and brain natriuretic peptides share binding sites in the kidney and heart. Eur J Pharmacol. 1989 Feb 28;161(2-3):159–164. doi: 10.1016/0014-2999(89)90838-8. [DOI] [PubMed] [Google Scholar]
  57. Ohyama Y., Miyamoto K., Saito Y., Minamino N., Kangawa K., Matsuo H. Cloning and characterization of two forms of C-type natriuretic peptide receptor in rat brain. Biochem Biophys Res Commun. 1992 Mar 16;183(2):743–749. doi: 10.1016/0006-291x(92)90546-w. [DOI] [PubMed] [Google Scholar]
  58. Okolicany J., McEnroe G. A., Koh G. Y., Lewicki J. A., Maack T. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol. 1992 Sep;263(3 Pt 2):F546–F553. doi: 10.1152/ajprenal.1992.263.3.F546. [DOI] [PubMed] [Google Scholar]
  59. Oron Y., Straub R. E., Traktman P., Gershengorn M. C. Decreased TRH receptor mRNA activity precedes homologous downregulation: assay in oocytes. Science. 1987 Dec 4;238(4832):1406–1408. doi: 10.1126/science.2825350. [DOI] [PubMed] [Google Scholar]
  60. Pandey K. N., Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem. 1990 Jul 25;265(21):12342–12348. [PubMed] [Google Scholar]
  61. Parker T. G., Schneider M. D. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol. 1991;53:179–200. doi: 10.1146/annurev.ph.53.030191.001143. [DOI] [PubMed] [Google Scholar]
  62. Porter J. G., Arfsten A., Fuller F., Miller J. A., Gregory L. C., Lewicki J. A. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun. 1990 Sep 14;171(2):796–803. doi: 10.1016/0006-291x(90)91216-f. [DOI] [PubMed] [Google Scholar]
  63. Porter J. G., Catalano R., McEnroe G., Lewicki J. A., Protter A. A. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992 Nov;263(5 Pt 1):C1001–C1006. doi: 10.1152/ajpcell.1992.263.5.C1001. [DOI] [PubMed] [Google Scholar]
  64. Qing G., Garcia R. Characterisation of plasma and tissue atrial natriuretic factor during development of moderate high output heart failure in the rat. Cardiovasc Res. 1993 Mar;27(3):464–470. doi: 10.1093/cvr/27.3.464. [DOI] [PubMed] [Google Scholar]
  65. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev. 1992 Dec;44(4):479–602. [PubMed] [Google Scholar]
  66. Rutherford R. A., Wharton J., Gordon L., Moscoso G., Yacoub M. H., Polak J. M. Endocardial localization and characterization of natriuretic peptide binding sites in human fetal and adult heart. Eur J Pharmacol. 1992 Feb 25;212(1):1–7. doi: 10.1016/0014-2999(92)90064-b. [DOI] [PubMed] [Google Scholar]
  67. Ruzicka M., Yuan B., Harmsen E., Leenen F. H. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation. 1993 Mar;87(3):921–930. doi: 10.1161/01.cir.87.3.921. [DOI] [PubMed] [Google Scholar]
  68. Sarkar G., Sommer S. S. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science. 1989 Apr 21;244(4902):331–334. doi: 10.1126/science.2565599. [DOI] [PubMed] [Google Scholar]
  69. Schiffrin E. L. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci (Lond) 1988 Feb;74(2):213–218. doi: 10.1042/cs0740213. [DOI] [PubMed] [Google Scholar]
  70. Schulz S., Singh S., Bellet R. A., Singh G., Tubb D. J., Chin H., Garbers D. L. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 1989 Sep 22;58(6):1155–1162. doi: 10.1016/0092-8674(89)90513-8. [DOI] [PubMed] [Google Scholar]
  71. Seidman C. E., Duby A. D., Choi E., Graham R. M., Haber E., Homcy C., Smith J. A., Seidman J. G. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science. 1984 Jul 20;225(4659):324–326. doi: 10.1126/science.6234658. [DOI] [PubMed] [Google Scholar]
  72. Stingo A. J., Clavell A. L., Aarhus L. L., Burnett J. C., Jr Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992 Jan;262(1 Pt 2):H308–H312. doi: 10.1152/ajpheart.1992.262.1.H308. [DOI] [PubMed] [Google Scholar]
  73. Stingo A. J., Clavell A. L., Heublein D. M., Wei C. M., Pittelkow M. R., Burnett J. C., Jr Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992 Oct;263(4 Pt 2):H1318–H1321. doi: 10.1152/ajpheart.1992.263.4.H1318. [DOI] [PubMed] [Google Scholar]
  74. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  75. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):863–870. doi: 10.1016/0006-291x(90)92401-k. [DOI] [PubMed] [Google Scholar]
  76. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992 Jan;130(1):229–239. doi: 10.1210/endo.130.1.1309330. [DOI] [PubMed] [Google Scholar]
  77. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest. 1992 Sep;90(3):1145–1149. doi: 10.1172/JCI115933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Takahashi T., Allen P. D., Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res. 1992 Jul;71(1):9–17. doi: 10.1161/01.res.71.1.9. [DOI] [PubMed] [Google Scholar]
  79. Takeda N., Nakamura I., Okubo T., Nagano M. Altered myocardial contractility and energetics in hypertrophied myocardium. Jpn Circ J. 1990 May;54(5):540–546. doi: 10.1253/jcj.54.540. [DOI] [PubMed] [Google Scholar]
  80. Tei M., Horie M., Makita T., Suzuki H., Hazama A., Okada Y., Kawai C. Atrial natriuretic peptide reduces the basal level of cytosolic free Ca2+ in guinea pig cardiac myocytes. Biochem Biophys Res Commun. 1990 Mar 16;167(2):413–418. doi: 10.1016/0006-291x(90)92038-2. [DOI] [PubMed] [Google Scholar]
  81. Tsunoda K., Mendelsohn F. A., Sexton P. M., Chai S. Y., Hodsman G. P., Johnston C. I. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circ Res. 1988 Jan;62(1):155–161. doi: 10.1161/01.res.62.1.155. [DOI] [PubMed] [Google Scholar]
  82. Tsutamoto T., Kanamori T., Wada A., Kinoshita M. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol. 1992 Sep;20(3):541–546. doi: 10.1016/0735-1097(92)90005-8. [DOI] [PubMed] [Google Scholar]
  83. Ueda S., Minamino N., Aburaya M., Kangawa K., Matsukura S., Matsuo H. Distribution and characterization of immunoreactive porcine C-type natriuretic peptide. Biochem Biophys Res Commun. 1991 Mar 29;175(3):759–767. doi: 10.1016/0006-291x(91)91631-l. [DOI] [PubMed] [Google Scholar]
  84. Wei Y. F., Rodi C. P., Day M. L., Wiegand R. C., Needleman L. D., Cole B. R., Needleman P. Developmental changes in the rat atriopeptin hormonal system. J Clin Invest. 1987 May;79(5):1325–1329. doi: 10.1172/JCI112957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Wilcox J. N., Augustine A., Goeddel D. V., Lowe D. G. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol. 1991 Jul;11(7):3454–3462. doi: 10.1128/mcb.11.7.3454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Wilkins M. R., Settle S. L., Stockmann P. T., Needleman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6465–6469. doi: 10.1073/pnas.87.16.6465. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES